NASDAQ
GT Biopharma, Inc. (GTBP) has a current ratio of 3.50x as of Monday, May 25, 2026. This represents a 49.93% increase compared to its 12-month average of 2.33x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.